Division of Extramural Activities
Site map
Contact us
Home
|
Funding
|
Advisory
|
NCI Research Priorities
|
Funded Awards
|
Research Resources
|
Events
|
NCI News
advanced search
National Cancer Advisory Board
Presentations from the 139th meeting held:
September 6-7, 2006
Quick Links
Day One (09/06/06)
Day Two (09/07/06)
Members
Meeting Minutes
NCAB Orientation Book
NCAB: Page 1
Adobe Acrobat
Reader is necessary
to view PDF files.
If needed, please
click
here
for free
download.
September 06
NIH VIDEOCAST
NCI Director's Update
Dr. Niederhuber
NCI Legislative Update
Ms. Erickson
Report of the American Society of Clinical Oncology
Dr. Hortobagyi
NCI Community-Based Cancer Centers Pilot Program
Dr. Niederhuber
Status Report: The Cancer Genome Atlas Pilot Project
Dr. Barker
Tamoxifen and Star Trial Results:
National Surgical Adjuvant Breast and Bowel Project (NSABP}
Dr. Wickerham
Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer:
Report of the Adolescent and Young Adult Oncology Progress Review Group (AYAO)
Ms. Nichols
Dr. Anderson
Dr. Caligiuri
Dr. Albritton
Scientific Update: Center for Cancer Research
Introduction
Influence of host genetics on HIV
The Applications of Microarrays and Aftificial Neural Networks for Diagnosis, Prognosis and
Selection of Therapuetic Targets
Research Program of the Cancer Redox Faculty
Trans-Institute Anguigenesis Research Program (TARP)
Dr. Wiltrout
Dr. Carrington
Dr. Khan
Dr. Wink
Dr. Libutti
top
September 07
NIH VIDEOCAST
NCI Cancer Centers Director's Report
Accelerating Successes Against Cancer: Recommendations from the
NCI Designated Cancer Center Directors
Treatment, Survivorship, Collaboration, and Dissemination
Dr. Mendelsohn
Dr. Abeloff
The NCI's Rapid Access to Intervention Development Program "RAID"
Report of the Workshop to Review the National Cancer Institute's Rapid Access to
Intervention Development (RAID) Program
DCTD RAID Action Plan: Response to RAID Workshop Report and Recommendations
Dr. Tomaszewski
Dr. Mendelsohn
Dr. Doroshow
Innovative Molecular Analysis Technologies (IMAT) for Cancer Program
Developing tests for Bcr-Abl activity and Gleevec resistance in CML patients
Dr. Downing
Dr. Kron
Annual Cancer Statistics: Rates, Trends, and Data on Hispanic/Latino Populations
Dr. Edwards
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Department of Health & Human Services (DHHS)
Related
Links
Privacy
Statement